Anticorps Monoclonal anti-4-1BBL/TNFSF9

• Phare
• Validé par KD/KO

4-1BBL/TNFSF9 Monoclonal Antibody for WB, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IHC, IF, ELISA

Conjugaison

Non conjugué

Publications(6)

CloneNo.

1B4B1

N° de cat : 66450-1-Ig

Synonymes

TNFSF9, 1B4B1, 4 1BB L, 4 1BB ligand, 4 1BBL

---

Galerie de données de validation

• 

  WB analysis using 66450-1-Ig

  Various lysates were subjected to SDS PAGE followed by western blot with 66450-1-Ig (4-1BBL/TNFSF9 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours.

---

Applications testées

• Résultats positifs en WB: cellules SKOV-3, cellules Raji, cellules SW-1990

Dilution recommandée

• Western Blot (WB): WB : 1:5000-1:50000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 2 publications below
• WB: See 5 publications below
• IHC: See 2 publications below
• IF: See 1 publications below

Informations sur le produit

66450-1-Ig cible 4-1BBL/TNFSF9 dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain
• Hôte / Isotype: Mouse / IgG1
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: 4-1BBL/TNFSF9 Protéine recombinante Ag12768
• Nom complet: tumor necrosis factor (ligand) superfamily, member 9
• Masse moléculaire calculée: 254 aa, 27 kDa
• Poids moléculaire observé: 27 kDa
• Numéro d’acquisition GenBank: BC104805
• Symbole du gène: TNFSF9
• Identification du gène (NCBI): 8744
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine G
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

TNFSF9, also named as 4-1BBL, belongs to the tumor necrosis factor family. It is a cytokine that binds to TNFRSF9. TNFSF9 induces the proliferation of activated peripheral blood T-cells. It may have a role in activation-induced cell death (AICD) and may play a role in cognate interactions between T-cells and B-cells/macrophages.

Publications

Species	Application	Title
human	WB,IHC	Aging (Albany NY); TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages.; Authors - Jiao Wu ; KD Validated
human	WB,IF	Int Immunopharmacol; TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through Src/FAK/p-Akt/IL-1β signaling; Authors - Jiao Wu ; KD Validated
human	IHC	BMC Cancer; Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis; Authors - Wenting Tang
human	WB	Hepatol Commun; HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma; Authors - Zhizhen Li
human	WB	bioRxiv; Leucine Aminopeptidase LyLAP enables lysosomal degradation of membrane proteins; Authors - Aakriti Jain
human	WB	Science; Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins; Authors - Aakriti Jain

{{ptg:RelatedPrimaryAntibodies}}